BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26578033)

  • 1. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition.
    Gelband H; Sankaranarayanan R; Gauvreau CL; Horton S; Anderson BO; Bray F; Cleary J; Dare AJ; Denny L; Gospodarowicz MK; Gupta S; Howard SC; Jaffray DA; Knaul F; Levin C; Rabeneck L; Rajaraman P; Sullivan T; Trimble EL; Jha P;
    Lancet; 2016 May; 387(10033):2133-2144. PubMed ID: 26578033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding global access to radiotherapy.
    Atun R; Jaffray DA; Barton MB; Bray F; Baumann M; Vikram B; Hanna TP; Knaul FM; Lievens Y; Lui TY; Milosevic M; O'Sullivan B; Rodin DL; Rosenblatt E; Van Dyk J; Yap ML; Zubizarreta E; Gospodarowicz M
    Lancet Oncol; 2015 Sep; 16(10):1153-86. PubMed ID: 26419354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition.
    Jamison DT; Alwan A; Mock CN; Nugent R; Watkins D; Adeyi O; Anand S; Atun R; Bertozzi S; Bhutta Z; Binagwaho A; Black R; Blecher M; Bloom BR; Brouwer E; Bundy DAP; Chisholm D; Cieza A; Cullen M; Danforth K; de Silva N; Debas HT; Donkor P; Dua T; Fleming KA; Gallivan M; Garcia PJ; Gawande A; Gaziano T; Gelband H; Glass R; Glassman A; Gray G; Habte D; Holmes KK; Horton S; Hutton G; Jha P; Knaul FM; Kobusingye O; Krakauer EL; Kruk ME; Lachmann P; Laxminarayan R; Levin C; Looi LM; Madhav N; Mahmoud A; Mbanya JC; Measham A; Medina-Mora ME; Medlin C; Mills A; Mills JA; Montoya J; Norheim O; Olson Z; Omokhodion F; Oppenheim B; Ord T; Patel V; Patton GC; Peabody J; Prabhakaran D; Qi J; Reynolds T; Ruacan S; Sankaranarayanan R; Sepúlveda J; Skolnik R; Smith KR; Temmerman M; Tollman S; Verguet S; Walker DG; Walker N; Wu Y; Zhao K
    Lancet; 2018 Mar; 391(10125):1108-1120. PubMed ID: 29179954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential surgery: key messages from Disease Control Priorities, 3rd edition.
    Mock CN; Donkor P; Gawande A; Jamison DT; Kruk ME; Debas HT;
    Lancet; 2015 May; 385(9983):2209-19. PubMed ID: 25662414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, content and financing of an essential national package of health services.
    Bobadilla JL; Cowley P; Musgrove P; Saxenian H
    Bull World Health Organ; 1994; 72(4):653-62. PubMed ID: 7923544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis.
    Ward ZJ; Scott AM; Hricak H; Atun R
    Lancet Oncol; 2021 Mar; 22(3):341-350. PubMed ID: 33662286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition.
    Prabhakaran D; Anand S; Watkins D; Gaziano T; Wu Y; Mbanya JC; Nugent R;
    Lancet; 2018 Mar; 391(10126):1224-1236. PubMed ID: 29108723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global health from a cancer care perspective.
    Pesec M; Sherertz T
    Future Oncol; 2015; 11(15):2235-45. PubMed ID: 26235185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of cancer care and control in countries of low and middle income: a call to action.
    Farmer P; Frenk J; Knaul FM; Shulman LN; Alleyne G; Armstrong L; Atun R; Blayney D; Chen L; Feachem R; Gospodarowicz M; Gralow J; Gupta S; Langer A; Lob-Levyt J; Neal C; Mbewu A; Mired D; Piot P; Reddy KS; Sachs JD; Sarhan M; Seffrin JR
    Lancet; 2010 Oct; 376(9747):1186-93. PubMed ID: 20709386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource requirements for essential universal health coverage: a modelling study based on findings from Disease Control Priorities, 3rd edition.
    Watkins DA; Qi J; Kawakatsu Y; Pickersgill SJ; Horton SE; Jamison DT
    Lancet Glob Health; 2020 Jun; 8(6):e829-e839. PubMed ID: 32446348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.
    Mills KT; Bundy JD; Kelly TN; Reed JE; Kearney PM; Reynolds K; Chen J; He J
    Circulation; 2016 Aug; 134(6):441-50. PubMed ID: 27502908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guide posts for investment in primary health care and projected resource needs in 67 low-income and middle-income countries: a modelling study.
    Stenberg K; Hanssen O; Bertram M; Brindley C; Meshreky A; Barkley S; Tan-Torres Edejer T
    Lancet Glob Health; 2019 Nov; 7(11):e1500-e1510. PubMed ID: 31564629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis.
    Ward ZJ; Grover S; Scott AM; Woo S; Salama DH; Jones EC; El-Diasty T; Pieters BR; Trimble EL; Vargas HA; Hricak H; Atun R
    Lancet Oncol; 2020 Aug; 21(8):1089-1098. PubMed ID: 32758463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis.
    Ward ZJ; Scott AM; Hricak H; Abdel-Wahab M; Paez D; Lette MM; Vargas HA; Kingham TP; Atun R
    Lancet Oncol; 2020 Aug; 21(8):1077-1088. PubMed ID: 32758462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to Cancer Therapeutics in Low- and Middle-Income Countries.
    Ruff P; Al-Sukhun S; Blanchard C; Shulman LN
    Am Soc Clin Oncol Educ Book; 2016; 35():58-65. PubMed ID: 27249686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer in low and middle income countries (LMICs): a shifting tide in global health.
    Anderson BO; Ilbawi AM; El Saghir NS
    Breast J; 2015; 21(1):111-8. PubMed ID: 25444441
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.